The DOI matches its Crossref record; 592 of the 592 references it cites were found in a registry or an index.
NF-κB in biology and targeted therapy: new insights and translational implications
Open accessAbstract
NF-κB signaling has been discovered for nearly 40 years. Initially, NF-κB signaling was identified as a pivotal pathway in mediating inflammatory responses. However, with extensive and in-depth investigations, researchers have discovered that its role can be expanded to a variety of signaling mechanisms, biological processes, human diseases, and treatment options. In this review, we first scrutinize the research process of NF-κB signaling, and summarize the composition, activation, and regulatory mechanism of NF-κB signaling. We investigate the interaction of NF-κB signaling with other important pathways, including PI3K/AKT, MAPK, JAK-STAT, TGF-β, Wnt, Notch, Hedgehog, and TLR signaling. The physiological and pathological states of NF-κB signaling, as well as its intricate involvement in inflammation, immune regulation, and tumor microenvironment, are also explicated. Additionally, we illustrate how NF-κB signaling is involved in a variety of human diseases, including cancers, inflammatory and autoimmune diseases, cardiovascular diseases, metabolic diseases, neurological diseases, and COVID-19. Further, we discuss the therapeutic approaches targeting NF-κB signaling, including IKK inhibitors, monoclonal antibodies, proteasome inhibitors, nuclear translocation inhibitors, DNA binding inhibitors, TKIs, non-coding RNAs, immunotherapy, and CAR-T. Finally, we provide an outlook for research in the field of NF-κB signaling. We hope to present a stereoscopic, comprehensive NF-κB signaling that will inform future research and clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–592 of 592
Hansen, J. M., & Harris, C. (2004) · Antioxidants and Redox Signaling · doi:10.1089/152308604771978291 · Cited by 112
Zhou, W., Chen, X., Hu, Q., Chen, X., Chen, Y., & Huang, L. (2018) · BMC Cancer · doi:10.1186/s12885-018-4461-z · Cited by 112
Self-citationWatanabe, N., Iwamura, T., Shinoda, T., & Fujita, T. (1997) · The EMBO Journal · doi:10.1093/emboj/16.12.3609 · Cited by 111
Schröfelbauer, B., Polley, S., Behar, M., Ghosh, G., & Hoffmann, A. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.04.020 · Cited by 111
Liu, X., Hogg, G. D., Zuo, C., Borcherding, N. C., Baer, J. M., Lander, V. E., Kang, L., Knolhoff, B. L., Ahmad, F. F., Osterhout, R. E., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.04.018 · Cited by 111
Proteasome Inhibition Sensitizes Non–Small-Cell Lung Cancer to Gemcitabine-Induced Apoptosis
Denlinger, C. E., Rundall, B. K., Keller, M. D., & Jones, D. R. (2004) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2004.04.029 · Cited by 110
Morrison, M. D., Reiley, W. W., Zhang, M., & Sun, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413634200 · Cited by 110
NF-κB-driven miR-34a impairs Treg/Th17 balance via targeting Foxp3
Xie, M., Wang, J., Gong, W., Xu, H., Pan, X., Chen, Y., Ru, S., Wang, H., Chen, X., Zhao, Y. C., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.04.018 · Cited by 110
Self-citationNF-κB signaling promotes castration-resistant prostate cancer initiation and progression
Thomas-Jardin, S. E., Dahl, H., Nawas, A. F., Bautista, M., & Delk, N. A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107538 · Cited by 110
Hasan, M., Gonugunta, V. K., Dobbs, N., Ali, A., Palchik, G. A., Calvaruso, M. A., DeBerardinis, R. J., & Yan, N. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611113114 · Cited by 108
Tu, E., Chia, C., Chen, W., Zhang, D., Park, S. A., Jin, W., Wang, D., Alegre, M., Zhang, Y. E., Sun, L., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.025 · Cited by 108
Huang, K., Liu, X., Li, Y., Wang, Q., Zhou, J., Wang, Y., Dong, F., Yang, C., Sun, Z., Fang, C., et al. (2019) · Advanced Science · doi:10.1002/advs.201900782 · Cited by 108
Zhang, P., Yang, Y., Nolo, R. M., Zweidler‐McKay, P. A., & Hughes, D. P. M. (2010) · Oncogene · doi:10.1038/onc.2010.62 · Cited by 107
Chen, J., Liu, G., Wang, X., Hong, H., Li, T., Li, L., Wang, H., Xie, J., Li, B., Li, T., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.09.009 · Cited by 107
Self-citationTan, D. S. W., Felip, E., de Castro, G., Solomon, B., Greystoke, A., Cho, B. C., Cobo, M., Kim, T. M., Ganguly, S., Carcereny, E., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00980 · Cited by 107
Chattopadhyay, M., Kodela, R., Nath, N., Barsegian, A., Boring, D. L., & Kashfi, K. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.019 · Cited by 106
Huang, S., Liu, D., Sun, J., Zhang, H., Zhang, J., Wang, Q., Gan, L., Qu, G., Qiu, J., Deng, J., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.12.013 · Cited by 106
Self-citationPascual, M., Mena‐Varas, M., Robles, E. F., Garcia-Barchino, M. J., Panizo, C., Hervás‐Stubbs, S., Alignani, D., Sagardoy, A., Martínez‐Ferrandis, J. I., Bunting, K. L., et al. (2019) · Blood · doi:10.1182/blood.2018889931 · Cited by 104
Sehnert, B., Burkhardt, H., Wessels, J. T., Schröder, A., May, M. J., Vestweber, D., Zwerina, J., Warnatz, K., Nimmerjahn, F., Schett, G. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218219110 · Cited by 102
Exosome-based delivery of super-repressor IκBα ameliorates kidney ischemia-reperfusion injury
Kim, S., Lee, S. A., Yoon, H., Kim, M. Y., Yoo, J.-K., Ahn, S.-H., Park, C. H., Park, J., Nam, B. Y., Park, J. T., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.04.039 · Cited by 100
Nomura, A., Majumder, K., Giri, B., Dauer, P., Dudeja, V., Roy, S., Banerjee, S., & Saluja, A. K. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.109 · Cited by 100
Wang, X., Yang, Z., Xu, X., Jiang, H., Cai, C., & Yu, G. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116261 · Cited by 100
Ahmad, S., Abbas, M., Ullah, M. F., Aziz, M. H., Beylerli, O., Alam, M. A., Syed, M. A., Shahab Uddin, M. S., & Ahmad, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.07.015 · Cited by 100
Strippoli, R., Benedicto, I., Foronda, M., Lozano, M. L. P., Sánchez-Perales, S., López‐Cabrera, M., & del Pozo, M. Á. (2010) · Journal of Cell Science · doi:10.1242/jcs.071647 · Cited by 99
Jelinkova, L. P., Tučková, L., Cinová, J., Flegelová, Z., & Tlaskalová-Hogenová, H. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.06.057 · Cited by 99
Proteasome Inhibitor PS-341 (Bortezomib) Induces Calpain-dependent IκBα Degradation
Li, C., Chen, S., Yue, P., Deng, X., Lonial, S., Khuri, F. R., & Sun, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.072694 · Cited by 99
Dolatshahi, M., Hameghavandi, M. H. R., Sabahi, M., & Rostamkhani, S. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15242 · Cited by 97
Turning NF-κB and IRFs on and off in DC
Kaisho, T., & Tanaka, T. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.03.005 · Cited by 96
TLR4 downregulation by the RNA-binding protein PUM1 alleviates cellular aging and osteoarthritis
Yoon, D. S., Lee, K., Choi, Y., Ko, E. A., Lee, N., Cho, S., Park, K. H., Lee, J., Kim, H., & Lee, J. W. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-021-00925-6 · Cited by 96
Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease
Renna, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.9675 · Cited by 95
Lu, W., Xu, Y., Shao, X., Gao, F., Li, Y., Hu, J., Zuo, Z., Shao, X., Zhou, L., Zhao, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep12144 · Cited by 95
Targeting β2-microglobulin for induction of tumor apoptosis in human hematological malignancies
Yang, J., Qian, J., Wezeman, M. J., Wang, S., Lin, P., Wang, M. L., Yaccoby, S., Kwak, L. W., Barlogie, B., & Yi, Q. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.025 · Cited by 94
Meteoğlu, İ., Erdoğdu, İ. H., Meydan, N., Erkuş, M., & Barutça, S. (2008) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-27-53 · Cited by 93
NF-κB–driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance
Chiu, C., Chang, Y.-W., Kuo, K.-T., Shen, Y.-S., Liu, C., Yu, Y., Cheng, C.-C., Lee, K., Chen, F., Hsu, M.-K., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522612113 · Cited by 93
Salusin-β contributes to oxidative stress and inflammation in diabetic cardiomyopathy
Zhao, M., Zhou, B. R., Li, L., Xiong, X., Zhang, F., Chen, Q., Li, Y., Kang, Y., & Zhu, G. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.106 · Cited by 93
Targeting B-cell receptor and PI3K signaling in diffuse large B-cell lymphoma
Xu, W., Berning, P., & Lenz, G. (2021) · Blood · doi:10.1182/blood.2020006784 · Cited by 93
Perivascular mesenchymal cells control adipose-tissue macrophage accrual in obesity
Shan, B., Shao, M., Zhang, Q., Hepler, C., Paschoal, V. A., Barnes, S. D., Vishvanath, L., An, Y., Jia, L., Malladi, V. S., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00301-7 · Cited by 92
NF-κB in the New Era of Cancer Therapy
Eluard, B., Thiéblemont, C., & Baud, V. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.04.003 · Cited by 91
Bai, R., Lang, Y., Shao, J., Deng, Y., Refuhati, R., & Cui, L. (2021) · ASN NEURO · doi:10.1177/17590914211018100 · Cited by 91
NOTCH inhibits osteoblast formation in inflammatory arthritis via noncanonical NF-κB
Zhang, H., Hilton, M. J., Anolik, J. H., Welle, S. L., Zhao, C., Yao, Z., Li, X., Wang, Z., Boyce, B. F., & Xing, L. (2014) · Journal of Clinical Investigation · doi:10.1172/jci68901 · Cited by 89
Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells
Suzuki, H., Suzuki, Y., Aizawa, M., Yamanaka, T., Kihara, M., Pang, H., Horikoshi, S., & Tomino, Y. (2007) · Kidney International · doi:10.1038/sj.ki.5002300 · Cited by 88
Lennikov, A., Mirabelli, P., Mukwaya, A., Schaupper, M., Thangavelu, M., Lachota, M., Ali, Z., Jensen, L. D., & Lagali, N. (2018) · Angiogenesis · doi:10.1007/s10456-018-9594-9 · Cited by 88
Sheller‐Miller, S., Radnaa, E., Yoo, J., Choi, K., Kim, Y., Kim, Y. N., Kim, E., Richardson, L., Choi, C., & Menon, R. (2021) · Science Advances · doi:10.1126/sciadv.abd3865 · Cited by 88
Du, F., Qi, X., Zhang, A., Sui, F., Wang, X., Proud, C. G., Lin, C., Fan, X., & Li, J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00670-3 · Cited by 86
Schwarzer, R., Dörken, B., & Jundt, F. (2011) · Leukemia · doi:10.1038/leu.2011.265 · Cited by 85
Richardson, P. G. G., Zimmerman, T. M., Hofmeister, C. C., Talpaz, M., Chanan-Khan, A. A., Kaufman, J. L., Laubach, J. P., Chauhan, D., Jakubowiak, A. J., Reich, S. D., et al. (2016) · Blood · doi:10.1182/blood-2015-12-686378 · Cited by 85
Voss, O. H., Murakami, Y., Peña, M., Lee, H., Tian, L., Margulies, D. H., Street, J. M., Yuen, P. S. T., Qi, C., Krzewski, K., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.005 · Cited by 85
Otano, I., Azpilikueta, A., Glez‐Vaz, J., Álvarez, M., Medina‐Echeverz, J., Cortés‐Domínguez, I., Ortíz-de-Solórzano, C., Ellmark, P., Fritzell, S., Hernández‐Hoyos, G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27613-w · Cited by 85
Aerobic glycolysis enhances HBx-initiated hepatocellular carcinogenesis via NF-κBp65/HK2 signalling
Chen, L., Lin, X., Lei, Y., Xu, X., Zhou, Q., Chen, Y., Liu, H., Jiang, J., Yang, Y., Zheng, F., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02531-x · Cited by 85
A NIK–SIX signalling axis controls inflammation by targeted silencing of non-canonical NF-κB
Liu, Z., Mar, K. B., Hanners, N. W., Perelman, S. S., Kanchwala, M., Xing, C., Schoggins, J. W., & Alto, N. M. (2019) · Nature · doi:10.1038/s41586-019-1041-6 · Cited by 84
NF-κB Shapes Metabolic Adaptation by Attenuating Foxo-Mediated Lipolysis in Drosophila
Molaei, M., Vandehoef, C., & Karpac, J. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.009 · Cited by 84
Circadian clock dysfunction in human omental fat links obesity to metabolic inflammation
Maury, E., Navez, B., & Brichard, S. M. (2021) · Nature Communications · doi:10.1038/s41467-021-22571-9 · Cited by 83
Wang, Y.-J., Wang, J.-T., Fan, Q.-X., & Geng, J.-G. (2007) · Cell Research · doi:10.1038/cr.2007.89 · Cited by 80
Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling
Liu, F., Mischel, P. S., & Cavenee, W. K. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0005-2 · Cited by 80
Interleukin-7 induces recruitment of monocytes/macrophages to endothelium
Li, R., Paul, A., Ko, K. W. S., Sheldon, M., Rich, B. E., Terashima, T., Dieker, C., Cormier, S., Li, L., Nour, E. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr245 · Cited by 79
Zhu, Y., Shen, T., Lin, Y., Chen, B., Ruan, Y., Cao, Y., Qiao, Y., Man, Y., Wang, S., & Li, J. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.46 · Cited by 79
Harrison, S. J., Mainwaring, P. N., Price, T. J., Millward, M., Padrik, P., Underhill, C. R., Cannell, P., Reich, S. D., Trikha, M., & Spencer, A. G. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2616 · Cited by 79
Gan, L., Li, Z., Lv, Q.-K., & Huang, W. Y. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118449 · Cited by 77
Matrix compliance permits NF-κB activation to drive therapy resistance in breast cancer
Drain, A. P., Zahir, N., Northey, J. J., Zhang, H., Huang, P., Maller, O., Lakins, J. N., Yu, X., Leight, J. L., Alston‐Mills, B., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20191360 · Cited by 77
The non-canonical NF-κB pathway and its contribution to β-cell failure in diabetes
Meyerovich, K., Ortis, F., & Cardozo, A. K. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0183 · Cited by 75
Gugliandolo, E., Fusco, R., D’Amico, R., Militi, A., Oteri, G., Wallace, J. L., Paola, R. D., & Cuzzocrea, S. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.022 · Cited by 72
Diabetes Activates Periodontal Ligament Fibroblasts via NF-κB In Vivo
Zheng, J., Chen, S., Albiero, M. L., Vieira, G. H. A., Wang, J., Feng, J. Q., & Graves, D. T. (2018) · Journal of Dental Research · doi:10.1177/0022034518755697 · Cited by 72
Hyperglycemia Induces Myocardial Dysfunction via Epigenetic Regulation of JunD
Hussain, S., Khan, A. W., Akhmedov, A. T., Suades, R., Costantino, S., Paneni, F., Caidahl, K., Mohammed, S. A., Hage, C., Gkolfos, C., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.317132 · Cited by 72
Tian, P., Zhao, L., Kim, J., Li, X., Liu, C., Cui, X., Liang, T., Du, Y., Chen, X., & Pan, H. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.02.023 · Cited by 72
Self-citationAzuma, K., Ikeda, K., Suzuki, T., Aogi, K., Horie‐Inoue, K., & Inoue, S. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100784118 · Cited by 71
Liu, H., Zang, C., Fenner, M. H., Liu, D., Possinger, K., Koeffler, H. P., & Elstner, E. (2006) · Blood · doi:10.1182/blood-2005-05-2103 · Cited by 70
NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma
Wang, H., Pan, J., Luo, L., Ning, X., Ye, Z.-P., Yu, Z., & Li, W. (2015) · Molecular Cancer · doi:10.1186/1476-4598-14-2 · Cited by 70
Li, C., Xue, V. W., Wang, Q., Lian, G., Huang, X., Lee, T., To, K., Tang, P. M., & Lan, H. Y. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0782 · Cited by 70
The Fire Within: NF-κB Involvement in Non–Small Cell Lung Cancer
Dimitrakopoulos, F.-I. D., Kottorou, A. E., Kalofonou, M., & Kalofonos, H. P. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3578 · Cited by 70
Regulation of TNF-induced NF-κB activation by different cytoplasmic ubiquitination events
Verhelst, K., Carpentier, I., & Beyaert, R. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.11.002 · Cited by 69
Trigueros‐Motos, L., González, J. M., Cheung, C., Fernández, P., Sánchez‐Cabo, F., Dopazo, A., Sinha, S., & Andrés, V. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300539 · Cited by 69
Spitschak, A., Meier, C., Kowtharapu, B. S., Engelmann, D., & Pützer, B. M. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0563-x · Cited by 69
Nolan, G. P., Fujita, T., Bhatia, K. G., Huppi, C., Liou, H., Scott, M. L., & Baltimore, D. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3557-3566.1993 · Cited by 69
Reid, M. A., Lowman, X. H., Pan, M., Tran, T. Q., Warmoes, M. O., Gabra, M. B. I., Yang, Y., Locasale, J. W., & Kong, M. (2016) · Genes & Development · doi:10.1101/gad.287235.116 · Cited by 68
The Many Roles of Ubiquitin in NF-κB Signaling
Courtois, G., & Fauvarque, M. (2018) · Biomedicines · doi:10.3390/biomedicines6020043 · Cited by 68
Szymura, S. J., Zaemes, J. P., Allison, D. F., Clift, S. H., D'Innocenzi, J., Gray, L. G., McKenna, B. D., Morris, B. B., Bekiranov, S., LeGallo, R. D., et al. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0335-5 · Cited by 68
Ciarcia, R., Vitiello, M. T., Galdiero, M., Pacilio, C., Iovane, V., d’Angelo, D., Pagnini, D., Caparrotti, G., Conti, D., Tomei, V., et al. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.23029 · Cited by 67
Vavricka, S. R., Galván, J. A., Dawson, H., Soltermann, A., Biedermann, L., Scharl, M. M., Schoepfer, A. M., Rogler, G., Vavricka, M. P., Terracciano, L., et al. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx158 · Cited by 67
TAK -ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy
Santoro, R., Carbone, C., Piro, G., Chiao, P. J., & Melisi, D. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.10.004 · Cited by 65
Substrate-specific recognition of IKKs mediated by USP16 facilitates autoimmune inflammation
Yu, J.-S., Huang, T., Zhang, Y., Mao, X.-T., Huang, L.-J., Li, Y., Wu, T.-T., Zhong, J.-Y., Cao, Q., Li, Y., et al. (2021) · Science Advances · doi:10.1126/sciadv.abc4009 · Cited by 65
Enhanced triacylglycerol catabolism by carboxylesterase 1 promotes aggressive colorectal carcinoma
Capece, D., D’Andrea, D., Begalli, F., Goracci, L., Tornatore, L., Alexander, J. L., Veroli, A. D., Leow, S. C., Vaiyapuri, T. S., Ellis, J. K., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci137845 · Cited by 65
Receptor activator of NF-κB mediates podocyte injury in diabetic nephropathy
Ke, G., Chen, X., Liao, R., Xu, L., Zhang, L., Zhang, H., Kuang, S., Du, Y., Hu, J., Lian, Z., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.04.036 · Cited by 65
Self-citationYin, C., Ye, Z., Wu, J. H., Huang, C., Pan, L., Ding, H., Zhong, L., Guo, L., Zou, Y., Wang, X., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103745 · Cited by 65
Chen, M., Xie, H., Chen, Z., Xu, S., Wang, B., Peng, Q., Sha, K., Xiao, W., Liu, T., Zhang, Y., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109011 · Cited by 64
Raninga, P. V., Lee, A., Sinha, D., Dong, L., Datta, K. K., Lu, X. M., Croft, P. K., Dutt, M., Hill, M. M. C., Pouliot, N., et al. (2020) · Theranostics · doi:10.7150/thno.42705 · Cited by 64
Treatment of atopic dermatitis: Role of tacrolimus ointment as a topical noncorticosteroidal therapy
Fleischer, A. B. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70055-2 · Cited by 63
Lin, C., Tsai, P.-H., Kandaswami, C. C., Chang, G.-D., Cheng, C., Huang, C., Lee, P.-P., Hwang, J.-J., & Lee, M. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-87 · Cited by 62
Ge, Y., Xu, Y., Sun, W., Man, Z., Zhu, L., Xia, X., Zhao, L., Zhao, Y., & Wang, X. (2012) · Gene · doi:10.1016/j.gene.2012.07.045 · Cited by 62
Meyerovich, K., Fukaya, M., Terra, L. F., Ortis, F., Eizirik, D. L., & Cardozo, A. K. (2015) · Diabetologia · doi:10.1007/s00125-015-3817-z · Cited by 62
Zhang, Q., Wang, L., Chen, B., Zhuo, Q., Bao, C.-Y., & Lin, L. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.08.015 · Cited by 62
Venugopal, P., Koshy, T., Lavu, V., Rao, S. R., Ramasamy, S., Hariharan, S., & Venkatesan, V. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26391 · Cited by 62
Wang, Z., Gao, Z., Zheng, Y., Kou, J., Song, D., Yu, X. L., Dong, B., Chen, T., Yang, Y., Gao, X., et al. (2023) · Journal of Pineal Research · doi:10.1111/jpi.12855 · Cited by 62
T cell receptor/CARMA1/NF-κB signaling controls T-helper (Th) 17 differentiation
Molinero, L. L., Cubre, A., Mora-Solano, C., Wang, Y., & Alegre, M.-L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204557109 · Cited by 61
B-cell survival and development controlled by the coordination of NF-κB family members RelB and cRel
Almaden, J., Liu, Y. C., Yang, E., Otero, D. C., Birnbaum, H. A., Davis‐Turak, J., Asagiri, M., David, M., Goldrath, A. W., & Hoffmann, A. (2016) · Blood · doi:10.1182/blood-2014-10-606988 · Cited by 60
Feist, M., Schwarzfischer, P., Heinrich, P., Sun, X., Kemper, J., von Bonin, F., Pérez-Rubio, P., Taruttis, F., Rehberg, T., Dettmer, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03803-x · Cited by 59
NF-κB–Dependent Lymphoid Enhancer Co-option Promotes Renal Carcinoma Metastasis
Rodrigues, P., Patel, S. A., Harewood, L., Olan, I., Vojtasova, E., Syafruddin, S. E., Zaini, M. N., Richardson, E. K., Burge, J., Warren, A. Y., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1211 · Cited by 59
Sustained hyperammonemia induces TNF-a IN Purkinje neurons by activating the TNFR1-NF-κB pathway
Balzano, T., Arenas, Y. M., Dadsetan, S., Forteza, J., Gil‐Perotín, S., Cubas-Núñez, L., Casanova, B., Gracià, F., Varela-Andrés, N., Montoliu, C., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01746-z · Cited by 59
Puppala, E. R., Jain, S., Saha, P., Rachamalla, M., Syamprasad, N. P., Yalamarthi, S. S., Abubakar, M., Chaudhary, A., Chamundeswari, D., Murty, U. S. N., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.153926 · Cited by 59
Tan, Y., Zhou, H., Lin, Y.-J., Yi, L.-T., Chen, Z., Cao, Q., Guo, Y.-R., Wang, Z.-N., Chen, S., Li, Y., et al. (2022) · Military Medical Research · doi:10.1186/s40779-022-00366-3 · Cited by 59
NF-κB and Extrinsic Cell Death Pathways – Entwined Do-or-Die Decisions for T cells
Blanchett, S., Boal-Carvalho, I., Layzell, S., & Seddon, B. (2021) · Trends in Immunology · doi:10.1016/j.it.2020.10.013 · Cited by 58
Calmodulin dependence of NFκB activation
Hughes, K. A., Antonsson, Å., & Grundström, T. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01537-3 · Cited by 57
Kong, W., Ling, X., Chen, Y., Wu, X., Zhao, Z., Wang, W., Wang, S., Lai, G., & Yu, Z. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4485 · Cited by 57
Olazagoitia‐Garmendia, A., Zhang, L., Mera, P., Godbout, J. K., Sebastian‐delaCruz, M., García‐Santisteban, I., Mendoza, L. M., Huerta, A., Irastorza, I., Bhagat, G., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-322566 · Cited by 57
NF-κB dynamics in the language of immune cells
Aqdas, M., & Sung, M. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.11.005 · Cited by 56
Yuan, J., Zhang, J., Cao, J., Wang, G., & Bai, H. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00749-6 · Cited by 55
Self-citationMitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling
Dutta, K., Thammisetty, S. S., Boutej, H., Bareil, C., & Julien, J.-P. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.0536-20.2020 · Cited by 55
Chalabi‐Dchar, M., Cassant‐Sourdy, S., Duluc, C., Fanjul, M., Lulka, H., Samain, R., Roche, C., Breibach, F., Delisle, M., Poupot, M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.009 · Cited by 54
Guillermet‐Guibert, J., Saint‐Laurent, N., Davenne, L., Rochaix, P., Cuvillier, O., Culler, M. D., Pradayrol, L., Buscail, L., Susini, C., & Bousquet, C. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401939 · Cited by 54
Yang, S., Li, J., Chen, Y., Zhang, ., Feng, C., Hou, Z., Cai, J., Wang, Y., Hui, R., Lv, B., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.06.016 · Cited by 54
Aptamer-iRNAs as Therapeutics for Cancer Treatment
Soldevilla, M. M., Meraviglia-Crivelli, D., Menon, A. P., & Pastor, F. (2018) · Pharmaceuticals · doi:10.3390/ph11040108 · Cited by 54
Downregulation of ICAM-1 and VCAM-1 expression in endothelial cells treated by photodynamic therapy
Volanti, C., Gloire, G., Vanderplasschen, A. F. C., Jacobs, N., Habraken, Y., & Piette, J. G. (2004) · Oncogene · doi:10.1038/sj.onc.1207871 · Cited by 53
Tranter, M., Liu, Y., He, S., Gulick, J. M., Ren, X., Robbins, J. M., Jones, W. K., & Reineke, T. M. (2011) · Molecular Therapy · doi:10.1038/mt.2011.267 · Cited by 53
RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion
Zhang, Y., Zhu, S., Du, Y., Xu, F., Sun, W., Xu, Z., Wang, X., Qian, P., Zhang, Q., Feng, J., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02243-2 · Cited by 52
Anakinra for cryopyrin-associated periodic syndrome
Koné‐Paut, I., & Galeotti, C. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.861325 · Cited by 51
Zhang, Y., Huo, F., Wei, L., Gong, C., Pan, Y., Mou, J., & Pei, D. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0610-5 · Cited by 51
Rae, C. J., Langa, S., Tucker, S. J., & MacEwan, D. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701437104 · Cited by 50
Tertiary Lymphoid Structures in Rheumatoid Arthritis
Noort, A. R., van Zoest, K. P. M., van Baarsen, L. G. M., Maracle, C. X., Helder, B., Papazian, N., Romera‐Hernández, M., Tak, P. P., Cupedo, T., & Tas, S. W. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.03.012 · Cited by 49
Nuclear Factor κB Signaling and Its Related Non-coding RNAs in Cancer Therapy
Liu, X., Shao, Y., Zhou, J., Qian, G., & Ma, Z. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.11.007 · Cited by 49
Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis
Zeng, X., Zhou, J., Xiong, Z., Sun, H., Yang, W., Mok, M. T. S., Wang, J., Li, J., Liu, M., Tang, W., et al. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00534-2 · Cited by 49
Self-citationComposite CD79A/CD40 co-stimulatory endodomain enhances CD19CAR-T cell proliferation and survival
Julamanee, J., Terakura, S., Umemura, K., Adachi, Y., Miyao, K., Okuno, S., Takagi, E., Sakai, T., Koyama, D., Goto, T., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.038 · Cited by 49
Marienfeld, R. B., Palkowitsch, L., & Ghosh, S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00478-06 · Cited by 47
Quan, W., Liu, H., Zhang, W., Lou, W., Gong, Y.-Z., Yuan, C. G., Shao, Q., Wang, N., Guo, C., & Liu, F. (2021) · Pharmaceutical Biology · doi:10.1080/13880209.2021.1878236 · Cited by 47
Spatiotemporal NF-κB dynamics encodes the position, amplitude, and duration of local immune inputs
Son, M., Frank, T., Holst‐Hansen, T., Wang, A. G., Junkin, M., Kashaf, S. S., Trusina, A., & Tay, S. (2022) · Science Advances · doi:10.1126/sciadv.abn6240 · Cited by 47
Alwahsh, M., Farhat, J., Talhouni, S., Hamadneh, L., & Hergenröder, R. (2023) · EXCLI journal · doi:10.17179/excli2022-5653 · Cited by 47
NFAT and NF-κB dynamically co-regulate TCR and CAR signaling responses in human T cells
Huang, W. L., Lin, W., Chen, B., Zhang, J., Gao, P., Fan, Y., Lin, Y., & Wei, P. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112663 · Cited by 47
Self-citationDu, S., Deng, Y., Yuan, H.-J., & Sun, Y. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/7219740 · Cited by 45
Yoon, S.-B., Hong, H., Lim, H.-J., Choi, J. H., Choi, Y. P., Seo, S. W., Lee, H. W., Chae, C. H., Park, W.-K., Kim, H. Y., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.12.001 · Cited by 44
Challa, S., Guo, J.-P., Ding, X., Xu, C., Li, Y., Kim, D., Smith, M. A., Cress, W. D., Coppola, D., Haura, E. B., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0069 · Cited by 44
Webb, L. V., Barbarulo, A., Huysentruyt, J., Berghe, T. V., Takahashi, N., Ley, S. C., Vandenabeele, P., & Seddon, B. P. (2019) · Immunity · doi:10.1016/j.immuni.2019.01.004 · Cited by 44
Li, D., Luo, F., Guo, T., Han, S., Wang, H., & Lin, Q. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2026871 · Cited by 44
Tsai, Y.-R., Chang, C.-F., Lai, J.-H., Wu, J. C.-C., Chen, Y., Kang, S.-J., Hoffer, B. J., Tweedie, D., Luo, W., Greig, N. H., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103252 · Cited by 43
The Greatly Under-Represented Role of Smooth Muscle Cells in Atherosclerosis
Francis, G. A. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01145-8 · Cited by 43
NF-kB signaling in myeloid cells mediates the pathogenesis of immune-mediated nephritis
Chalmers, S. A., Garcia, S. J., Reynolds, J. A., Herlitz, L., & Putterman, C. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.11.004 · Cited by 42
Negrate, G. L. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01719.x · Cited by 41
IκB Kinase α Is Required for Development and Progression of KRAS -Mutant Lung Adenocarcinoma
Vreka, M., Lilis, I., Papageorgopoulou, M., Giotopoulou, G. A., Lianou, M., Giopanou, I., Kanellakis, N. I., Σπέλλα, Μ., Agalioti, T., Armenis, V., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1944 · Cited by 41
Loss of Tbk1 kinase activity protects mice from diet-induced metabolic dysfunction
Cruz, V. H., Arner, E. N., Wynne, K. W., Scherer, P. E., & Brekken, R. A. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.06.007 · Cited by 41
Gallego-Selles, Á., Galván-Álvarez, V., Martinez‐Canton, M., García-Gonzalez, E., Morales‐Álamo, D., Santana, A., González, J. J., Dorado, C., Calbet, J. A. L., & Martín-Rincón, M. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102398 · Cited by 41
Zhao, M., Chauhan, P. S., Sherman‐Baust, C. A., Singh, A., Kaileh, M., Mazan-Mamczarz, K., Ji, H., Joy, J. P., Nandi, S., De, S., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01561-7 · Cited by 41
JIANG, N., DONG, X.-P., Zhang, S., YOU, Q.-Y., Jiang, X., & Zhao, X. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4493 · Cited by 40
Huh, J. Y., & Saltiel, A. R. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00712-w · Cited by 40
Aberrant CD40-Induced NF-κB Activation in Human Lupus B Lymphocytes
Zhang, W., Shi, Q., Xu, X., Chen, H., Lin, W., Zhang, F., Zeng, X., Zhang, X., Ba, D., & He, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041644 · Cited by 39
Myeloid cell TBK1 restricts inflammatory responses
Gao, T., Liu, T., Ko, C., Zhang, L., Joo, D., Xie, X., Zhu, L., Li, Y., Cheng, X., & Sun, S. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107742119 · Cited by 39
Jang, J., Song, J., Lee, H., Sim, I., Kwon, Y. V., Jho, E., & Yoon, Y. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00577-z · Cited by 38
A negative feedback loop of ICER and NF-κB regulates TLR signaling in innate immune responses
Lv, S., Li, J., Qiu, X., Li, W., Zhang, C., Zhang, Z., & Luan, B. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.148 · Cited by 36
Diversity of NF-κB signalling and inflammatory heterogeneity in Rheumatic Autoimmune Disease
Manou-Stathopoulou, S., & Lewis, M. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2022.101649 · Cited by 36
Kawase, K., Kawashima, S., Nagasaki, J., Inozume, T., Tanji, E., Kawazu, M., Hanazawa, T., & Togashi, Y. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0815 · Cited by 36
Chorzalska, A. D., Morgan, J. W., Ahsan, N., Treaba, D. O., Olszewski, A. J., Petersen, M., Kingston, N. M., Cheng, Y., Lombardo, K. A., Schorl, C., et al. (2018) · Blood · doi:10.1182/blood-2018-05-848408 · Cited by 35
Su, J., Liu, F., Xia, M., Xu, Y., Li, X., KANG, J., Li, Y., & Sun, L. (2015) · Oncology Reports · doi:10.3892/or.2015.3944 · Cited by 34
Thalidomide Suppresses the Interleukin 1β‐Induced NFκB Signaling Pathway in Colon Cancer Cells
Jin, S. H., Kim, T. I., Han, D. S., Shin, S. K., & Kim, W. H. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04674.x · Cited by 34
He, Y., Li, J., Ding, N., Wang, X., Deng, L., Xie, Y., Ying, Z., Liu, W., Ping, L., Zhang, C., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1076-4 · Cited by 34
Xu, W., Berning, P., Erdmann, T., Grau, M., Bettazová, N., Zapukhlyak, M., Frontzek, F., Kosnopfel, C., Lenz, P., Grondine, M. R., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01749-0 · Cited by 34
Olmesartan Prevents Oligomerized Amyloid β (Aβ)-Induced Cellular Senescence in Neuronal Cells
Wang, J., Zheng, B. J., Yang, S., Zhou, D., & Wang, J. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00775 · Cited by 33
A Stk4-Foxp3–NF-κB p65 transcriptional complex promotes T reg cell activation and homeostasis
Cui, Y., Benamar, M., Schmitz‐Abe, K., Krishnan, V. P., Chen, Q., Jugder, B., Fatou, B., Fong, J. J. H., Zhong, Y., Mehta, S., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abl8357 · Cited by 33
Shedding Light on NF-κB Functions in Cellular Organelles
Carrà, G., Avalle, L., Seclì, L., Brancaccio, M., & Morotti, A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.841646 · Cited by 32
Wang, J.-C., Chen, D., Lu, S., Chen, J., Yuan, W., Liu, X., Tang, Y., Zhang, R., Chen, J., Kan, A., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-3899 · Cited by 32
Rare mendelian primary immunodeficiency diseases associated with impaired NF-κB signaling
Paciolla, M., Pescatore, A., Conte, M. I., Esposito, E., Incoronato, M., Lioi, M. B., Fusco, F., & Ursini, M. V. (2015) · Genes and Immunity · doi:10.1038/gene.2015.3 · Cited by 31
Yu, P., Li, Y., Fu, W., Li, X., Liu, Y., Wang, Y., Yu, X., Xu, H., & Sui, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.607813 · Cited by 31
K2P18.1 translates T cell receptor signals into thymic regulatory T cell development
Ruck, T., Böck, S., Pfeuffer, S., Schroeter, C. B., Cengiz, D., Marciniak, P., Lindner, M., Herrmann, A. M., Liebmann, M., Kovac, S., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00580-z · Cited by 30
Targeting phosphoinositide 3-kinases and histone deacetylases in multiple myeloma
Okabe, S., Tanaka, Y., & Gotoh, A. (2021) · Experimental Hematology and Oncology · doi:10.1186/s40164-021-00213-6 · Cited by 29
ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment
Liu, J., Hideshima, T., Xing, L., Wang, S., Zhou, W., Samur, M., Sewastianik, T., Ogiya, D., An, G., Gao, S., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg2697 · Cited by 29
Lim, S. K., Peng, C. C., Low, S., Vijay, V., Budiman, A., Phang, B. H., Lim, J. Q., Jeyasekharan, A. D. D., Lim, S. T., Ong, C. K., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01769-w · Cited by 29
Dishevelled interacts with p65 and acts as a repressor of NF-κB-mediated transcription
Deng, N., Ye, Y., Wang, W., & Li, L. (2010) · Cell Research · doi:10.1038/cr.2010.108 · Cited by 28
IκB kinase‐α coordinates BRD4 and JAK/STAT signaling to subvert DNA damage‐based anticancer therapy
Pecharromán, I., Solé, L., Villanueva, D. A., Lobo‐Jarne, T., Alonso‐Marañón, J., Bertran, J., Guillén, Y., Montoto, Á., Martínez‐Iniesta, M., García‐Hernández, V., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2023114719 · Cited by 28
Pleiotrophin drives a prometastatic immune niche in breast cancer
Ganguly, D., Schmidt, M. O., Coleman, M., Ngo, T.-V. C., Sorrelle, N. B., Dominguez, A. T. A., Murimwa, G. Z., Toombs, J. E., Lewis, C. M., Fang, Y. V., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20220610 · Cited by 27
The Tumor Suppressor Functions of Ubiquitin Ligase KPC1: From Cell-Cycle Control to NF-κB Regulator
Gulei, D., Drulă, R., Ghiaur, G., Buzoianu, A. D., Kravtsova‐Ivantsiv, Y., Tomuleasa, C., & Ciechanover, A. J. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-3739 · Cited by 25
Wang, Y., Pleasure, D., Deng, W., & Guo, F. (2021) · Advanced Science · doi:10.1002/advs.202102853 · Cited by 24
Yang, T., Sim, K.-Y., Ko, G.-H., Ahn, J., Kim, H., & Park, S. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02298-1 · Cited by 24
Octamer-dependent transcription in T cells is mediated by NFAT and NF-κB
Mueller, K., Quandt, J., Marienfeld, R. B., Weihrich, P., Fiedler, K., Claussnitzer, M., Laumen, H., Vaeth, M., Berberich‐Siebelt, F., Serfling, E., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1349 · Cited by 23
A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma
Wang, H., Wei, W., Zhang, J., Song, Z., Li, Y., Xiao, W., Liu, Y., Zeng, M., Petrus, M. N., Thomas, C. J., et al. (2020) · Leukemia · doi:10.1038/s41375-020-01088-y · Cited by 23
Self-citationXu, C., Fan, J., Liu, D., Tuerdi, A., Chen, J., Wei, Y., Pan, Y., Dang, H., Wei, X., Yousif, A. S., et al. (2022) · Hepatology · doi:10.1002/hep.32614 · Cited by 23
Yin, Q., Ma, J., Han, X., Zhang, H., Wang, F., Zhuang, P., & Zhang, Y. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105234 · Cited by 22
miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells
Tang, H., Lv, W., Sun, W., Bi, Q., & Hao, Y. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.4041 · Cited by 21
Therapeutic Potential of Astrocyte Purinergic Signalling in Epilepsy and Multiple Sclerosis
Nobili, P., Shen, W., Milicevic, K. D., Pristov, J. B., Audinat, É., & Nikolic, L. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.900337 · Cited by 21
Fang, C., Liu, J., Feng, M., Jia, Z., Li, Y., Dai, Y., Zhu, M., Huang, B., Liu, L., Wei, Z., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115441 · Cited by 21
Ottonello, L. C., Bertolotto, M. B., Montecucco, F., Bianchi, G., & Dallegri, F. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00162.x · Cited by 20
Wang, N., Cui, C., Xu, C., Ren, H., Wang, F., Yu, Q., & Zhang, G. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109100 · Cited by 20
Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure
Gehrke, N., Wörns, M., Mann, A., Hövelmeyer, N., Waisman, A., Straub, B. K., Galle, P. R., & Schattenberg, J. M. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04946-y · Cited by 18
Spohn, G., Arenas-Ramirez, N., Bouchaud, G., & Boyman, O. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.09.033 · Cited by 17
Metastasis-Associated Protein 2 Represses NF-κB to Reduce Lung Tumor Growth and Inflammation
El-Nikhely, N. A., Karger, A., Sarode, P., Singh, I., Weigert, A., Wietelmann, A., Stiewe, T., Dammann, R., Fink, L., Grimminger, F., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1158 · Cited by 17
Li, M., Li, L., Asemota, S., Kakhniashvili, D. G., Narayanan, R., Wang, X., & Liao, F. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123097119 · Cited by 17
Exosome-Based Delivery of Super-Repressor IκBα Alleviates Alcohol-Associated Liver Injury in Mice
Kim, H., Shim, Y., Choi, S. E., Falana, T. E., Yoo, J., Ahn, S., Park, M., Seo, H., Choi, C., & Jeong, W. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020636 · Cited by 17
Dimopoulos, M. A., Sonneveld, P., Siegel, D. S. D., Palumbo, A. P., & Miguel, J. F. S. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv325 · Cited by 16
Jaiswal, H., Ciucci, T., Wang, H., Tang, W., Claudio, E., Murphy, P. M., Bosselut, R., & Siebenlist, U. K. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009249 · Cited by 16
Wu, M., Wang, H., Shi, J., Sun, J., Duan, Z., Li, Y., Li, J., Hu, N., Wei, Y., Chen, Y., et al. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/21645515.2014.980682 · Cited by 12
Posada‐López, A., Botero, J. E., Pineda-Tamayo, R. A., & Agudelo‐Suárez, A. A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031789 · Cited by 12
Shibata, Y., Araki, H., Oshitani, T., Imaoka, A., Matsui, M., Miyazawa, K., & Abiko, Y. (2008) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2008.11.012 · Cited by 10
Zhang, W., Cheng, Y., Xiao, Y., Sun, Y., Lin, Y., Li, Q., & Cai, W. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1199785 · Cited by 10
Serological Biomarker-Based Machine Learning Models for Predicting the Relapse of Ulcerative Colitis
Pang, W., Zhang, B., Jin, L., Yao, Y., Han, Q., & Zheng, X.-L. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s423086 · Cited by 10
Birk‐Bachar, M., Cohen, H., Sofrin‐Drucker, E., et al. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42721 · Cited by 10
Nishida, Y., Iyadomi, M., Tominaga, H., Taniguchi, H., Higaki, Y., Tanaka, H., Horita, M., Shimanoe, C., Hara, M., & Tanaka, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030703 · Cited by 6
Tenascin-C provokes cardiac fibrosis and endothelial impairment in Duchenne Muscular Dystrophy
Szabo, P., Inci, M., Hilber, K., Abraham, D., Trojanek, S., Costantino, S., Paneni, F., Podesser, B. K., & Kiss, A. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac066.152 · Cited by 5
Dual role of ERK2/NF-κB signaling in TRAIL sensitivity.
Lee, M. W., Kim, D. S., Eom, J. E., Lee, J. W., Sung, K. W., Koo, H. H., Hong, Y. B., & Yoo, K. H. (2022) · PubMed · Cited by 1
Cited by
Free radicals and their impact on health and antioxidant defenses: a review
Chandimali, N., Bak, S. G., Park, E. H., Lim, H.-J., Won, Y.-S., Kim, E.-K., Park, S.-I., & Lee, S. J. (2025) · Cell Death Discovery · doi:10.1038/s41420-024-02278-8 · Cited by 669
Lu, P., Ruan, D., Huang, M., Tian, M., Zhu, K., Gan, Z., & Xiao, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01852-x · Cited by 667
Pattern recognition receptors: function, regulation and therapeutic potential
Chen, R., Zou, J., Chen, J., Zhong, X., Kang, R., & Tang, D. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02264-1 · Cited by 301
Helicobacter pylori and gastric cancer: mechanisms and new perspectives
Duan, Y., Xu, Y., Dou, Y., & Xu, D. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01654-2 · Cited by 300
The Role of Inflammation in Cancer: Mechanisms of Tumor Initiation, Progression, and Metastasis
Nishida, A., & Andoh, A. (2025) · Cells · doi:10.3390/cells14070488 · Cited by 270
Metadata
- Authors
- Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2024-03-04
- Volume
- 9
- Issue
- 1
- Pages
- 53-53
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4392343318
- Cited by
- 2,047
- References
- 592
- FWCI
- 313.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.